TY - JOUR
T1 - Patient similarity by joint matrix trifactorization to identify subgroups in acute myeloid leukemia
AU - Vitali, F.
AU - Marini, S.
AU - Pala, D.
AU - Demartini, A.
AU - Montoli, S.
AU - Zambelli, A.
AU - Bellazzi, R.
N1 - Publisher Copyright:
© The Author(s) 2018.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Objective: Computing patients' similarity is of great interest in precision oncology since it supports clustering and subgroup identification, eventually leading to tailored therapies. The availability of large amounts of biomedical data, characterized by large feature sets and sparse content, motivates the development of new methods to compute patient similarities able to fuse heterogeneous data sources with the available knowledge. Materials and Methods: In this work, we developed a data integration approach based on matrix trifactorization to compute patient similarities by integrating several sources of data and knowledge. We assess the accuracy of the proposed method: (1) on several synthetic data sets which similarity structures are affected by increasing levels of noise and data sparsity, and (2) on a real data set coming from an acute myeloid leukemia (AML) study. The results obtained are finally compared with the ones of traditional similarity calculation methods. Results: In the analysis of the synthetic data set, where the ground truth is known, we measured the capability of reconstructing the correct clusters, while in the AML study we evaluated the Kaplan-Meier curves obtained with the different clusters and measured their statistical difference by means of the log-rank test. In presence of noise and sparse data, our data integration method outperform other techniques, both in the synthetic and in the AML data. Discussion: In case of multiple heterogeneous data sources, a matrix trifactorization technique can successfully fuse all the information in a joint model. We demonstrated how this approach can be efficiently applied to discover meaningful patient similarities and therefore may be considered a reliable data driven strategy for the definition of new research hypothesis for precision oncology. Conclusion: The better performance of the proposed approach presents an advantage over previous methods to provide accurate patient similarities supporting precision medicine.
AB - Objective: Computing patients' similarity is of great interest in precision oncology since it supports clustering and subgroup identification, eventually leading to tailored therapies. The availability of large amounts of biomedical data, characterized by large feature sets and sparse content, motivates the development of new methods to compute patient similarities able to fuse heterogeneous data sources with the available knowledge. Materials and Methods: In this work, we developed a data integration approach based on matrix trifactorization to compute patient similarities by integrating several sources of data and knowledge. We assess the accuracy of the proposed method: (1) on several synthetic data sets which similarity structures are affected by increasing levels of noise and data sparsity, and (2) on a real data set coming from an acute myeloid leukemia (AML) study. The results obtained are finally compared with the ones of traditional similarity calculation methods. Results: In the analysis of the synthetic data set, where the ground truth is known, we measured the capability of reconstructing the correct clusters, while in the AML study we evaluated the Kaplan-Meier curves obtained with the different clusters and measured their statistical difference by means of the log-rank test. In presence of noise and sparse data, our data integration method outperform other techniques, both in the synthetic and in the AML data. Discussion: In case of multiple heterogeneous data sources, a matrix trifactorization technique can successfully fuse all the information in a joint model. We demonstrated how this approach can be efficiently applied to discover meaningful patient similarities and therefore may be considered a reliable data driven strategy for the definition of new research hypothesis for precision oncology. Conclusion: The better performance of the proposed approach presents an advantage over previous methods to provide accurate patient similarities supporting precision medicine.
KW - Acute myeloid leukemia (AML)
KW - Data integration
KW - Matrix trifactorization
KW - Patient similarity
KW - Precision medicine
UR - http://www.scopus.com/inward/record.url?scp=85061744160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061744160&partnerID=8YFLogxK
U2 - 10.1093/jamiaopen/ooy008
DO - 10.1093/jamiaopen/ooy008
M3 - Article
AN - SCOPUS:85061744160
SN - 2574-2531
VL - 1
SP - 75
EP - 86
JO - JAMIA Open
JF - JAMIA Open
IS - 1
ER -